Biatrial myxoma and cerebral ischemia successfully treated with intravenous thrombolytic therapy and surgical resection.
We report what we believe is the 1st case in the medical literature in which an intravenous thrombolytic agent was used successfully--without massive intracranial bleeding--to treat acute stroke induced by atrial myxoma. Our patient, who had biatrial myxomas with a dual blood supply from the right coronary artery, presented with cerebral ischemia. Transesophageal echocardiography was essential in clarifying the diagnosis and in helping to direct surgical treatment.
Ibrahim
Morhaf
M
Department of Internal Medicine, Division of Cardiology, and Department of Neurology at the University of Texas Health Science Center Medical School at Houston, Houston, Texas 77030, USA. Morhaf.Ibrahim@uth.tmc.edu
Iliescu
Cezar
C
Safi
Hazim J
HJ
Buja
Maximilian L
ML
McPherson
David D
DD
Fuentes
Francisco
F
D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006325:Heart Atria; D006338:Heart Neoplasms / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009232:Myxoma / Q000473:pathology / Q000601:surgery*; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator